Mutaib M. Mashraqi - Concepedia

Author

Mutaib M. Mashraqi

Najran University ORCID

Also Known As

Mashraqi, Mutaib M., Mutaib M Mashraqi, Mutaib M. Mashraqi, Mutaib Mashraqi, Mutaib Mosaued Mashraqi

Publications

501

Citations

H-Index

Concepts

All Affiliations

Najran University Shaqra University Taif University King Saud University National Guard Health Affairs

About

Mutaib M. Mashraqi is an author at Najran University specializing in drug discovery, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	71
2	Engineering	2	2	27
3	Immunology	2	2	44
4	Natural Sciences	1	1	31
5	Biochemistry	1	1	31

Mutaib M. Mashraqi

Publications

276

Citations

H-Index

Page 1

	Year	Citations
In-Silico Screening and Molecular Dynamics Simulation of Drug Bank Experimental Compounds against SARS-CoV-2 Norah A. Alturki, Mutaib M. Mashraqi, Ahmad Alzamami, Molecules	2022	77
Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study Ahmad Alzamami, Norah A. Alturki, Youssef Saeed Alghamdi, Medicina	2022	36
Development of a Candidate Multi-Epitope Subunit Vaccine against Klebsiella aerogenes: Subtractive Proteomics and Immuno-Informatics Approach Ahitsham Umar, Asma Haque, Youssef Saeed Alghamdi, Vaccines	2021	34
Novel Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2) and Other Coronaviruses: A Genome-wide Comparative Annotation and Analysis Mohammed Tarique, Shaban Ahmad, A.U. Malik, Molecular and Cellular Biochemistry	2021	32
Unveiling the multitargeted potential of N-(4-Aminobutanoyl)-S-(4-methoxybenzyl)-L-cysteinylglycine (NSL-CG) against SARS CoV-2: a virtual screening and molecular dynamics simulation study Youssef Saeed Alghamdi, Mutaib M. Mashraqi, Ahmad Alzamami, Journal of Biomolecular Structure and Dynamics ImmunologyAntiviral DrugViral Structural ProteinDrug BankPharmaceutical Chemistry	2022	31
Biocomputational Prediction Approach Targeting FimH by Natural SGLT2 Inhibitors: A Possible Way to Overcome the Uropathogenic Effect of SGLT2 Inhibitor Drugs Mutaib M. Mashraqi, Navaneet Chaturvedi, Qamre Alam, Molecules	2021	16
Therapeutic Target Identification and Inhibitor Screening against Riboflavin Synthase of Colorectal Cancer Associated Fusobacterium nucleatum Norah A. Alturki, Mutaib M. Mashraqi, Khurshid Jalal, Cancers BiosynthesisEngineeringDysbiosisMedicineWhole Genomes	2022	15
Anti-tubercular activity evaluation of natural compounds by targeting Mycobacterium tuberculosis resuscitation promoting factor B inhibition: An in silico study Ali A. Rabaan, Mohammed Garout, Mohammed Aljeldah, Molecular Diversity Pulmonary TuberculosisImmunologyPharmacologyTuberculosisFactor B Inhibition	2023	13
Mining therapeutic targets from the antibiotic-resistant Campylobacter coli and virtual screening of natural product inhibitors against its riboflavin synthase Khurshid Jalal, Kanwal Khan, Ajmal Hayat, Molecular Diversity Mining Therapeutic TargetsVirtual ScreeningEngineeringAntimicrobial SusceptibilityAntimicrobial Resistance Gene	2022	12
Unveiling the multitargeted repurposing potential of taxifolin (dihydroquercetin) in cervical cancer: an extensive MM\GBSA-based screening, and MD simulation study Hassan H. Almasoudi, Mohammed Ageeli Hakami, Abdulfattah Y. Alhazmi, Medical Oncology	2023	10

Page 1